193 related articles for article (PubMed ID: 15027856)
1. Unraveling the active conformation of urotensin II.
Carotenuto A; Grieco P; Campiglia P; Novellino E; Rovero P
J Med Chem; 2004 Mar; 47(7):1652-61. PubMed ID: 15027856
[TBL] [Abstract][Full Text] [Related]
2. Urotensin-II receptor ligands. From agonist to antagonist activity.
Grieco P; Carotenuto A; Campiglia P; Marinelli L; Lama T; Patacchini R; Santicioli P; Maggi CA; Rovero P; Novellino E
J Med Chem; 2005 Nov; 48(23):7290-7. PubMed ID: 16279788
[TBL] [Abstract][Full Text] [Related]
3. New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.
Grieco P; Carotenuto A; Campiglia P; Gomez-Monterrey I; Auriemma L; Sala M; Marcozzi C; d'Emmanuele di Villa Bianca R; Brancaccio D; Rovero P; Santicioli P; Meini S; Maggi CA; Novellino E
J Med Chem; 2009 Jul; 52(13):3927-40. PubMed ID: 19432421
[TBL] [Abstract][Full Text] [Related]
4. Urotensin-II receptor peptide agonists.
Carotenuto A; Grieco P; Novellino E; Rovero P
Med Res Rev; 2004 Sep; 24(5):577-88. PubMed ID: 15224381
[TBL] [Abstract][Full Text] [Related]
5. Urantide conformation and interaction with the urotensin-II receptor.
Brancaccio D; Limatola A; Campiglia P; Gomez-Monterrey I; Novellino E; Grieco P; Carotenuto A
Arch Pharm (Weinheim); 2014 Mar; 347(3):185-92. PubMed ID: 24357333
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, conformational analysis, and biological studies of urotensin-II lactam analogues.
Grieco P; Carotenuto A; Patacchini R; Maggi CA; Novellino E; Rovero P
Bioorg Med Chem; 2002 Dec; 10(12):3731-9. PubMed ID: 12413830
[TBL] [Abstract][Full Text] [Related]
7. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay.
Brkovic A; Hattenberger A; Kostenis E; Klabunde T; Flohr S; Kurz M; Bourgault S; Fournier A
J Pharmacol Exp Ther; 2003 Sep; 306(3):1200-9. PubMed ID: 12807997
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
Chatenet D; Dubessy C; Boularan C; Scalbert E; Pfeiffer B; Renard P; Lihrmann I; Pacaud P; Tonon MC; Vaudry H; Leprince J
J Med Chem; 2006 Nov; 49(24):7234-8. PubMed ID: 17125276
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
[TBL] [Abstract][Full Text] [Related]
10. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
11. New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide.
Carotenuto A; Auriemma L; Merlino F; Limatola A; Campiglia P; Gomez-Monterrey I; di Villa Bianca Rd; Brancaccio D; Santicioli P; Meini S; Maggi CA; Novellino E; Grieco P
J Pept Sci; 2013 May; 19(5):293-300. PubMed ID: 23526702
[TBL] [Abstract][Full Text] [Related]
12. Identification of new agonists of urotensin-II from a cyclic peptide library.
Odagami T; Tsuda Y; Kogami Y; Kouji H; Okada Y
Bioorg Med Chem; 2009 Sep; 17(18):6742-7. PubMed ID: 19695883
[TBL] [Abstract][Full Text] [Related]
13. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
14. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.
Holleran BJ; Beaulieu ME; Proulx CD; Lavigne P; Escher E; Leduc R
Biochem J; 2007 Feb; 402(1):51-61. PubMed ID: 17064254
[TBL] [Abstract][Full Text] [Related]
15. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
[TBL] [Abstract][Full Text] [Related]
16. Conformational analyses of sandostatin analogs containing stereochemical changes in positions 6 or 8.
Mattern RH; Zhang L; Rueter JK; Goodman M
Biopolymers; 2000 May; 53(6):506-22. PubMed ID: 10775066
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II.
Boivin S; Ségalas-Milazzo I; Guilhaudis L; Oulyadi H; Fournier A; Davoust D
Peptides; 2008 May; 29(5):700-10. PubMed ID: 18423797
[TBL] [Abstract][Full Text] [Related]
18. Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain.
Boucard AA; Sauvé SS; Guillemette G; Escher E; Leduc R
Biochem J; 2003 Mar; 370(Pt 3):829-38. PubMed ID: 12495432
[TBL] [Abstract][Full Text] [Related]
19. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
